Westwicke Partners is a strategic capital markets advisory firm that provides customized investor relations programs and independent capital markets advice to small and mid-cap healthcare companies.
We work with private and public companies to help position their story properly within the investment community and to develop value-added strategies to build a quality, long-term shareholder base and enhance equity market value.
Our background is unique. Our partners all come directly from Wall Street as former sell-side research analysts, institutional salesmen, investment bankers, equity capital markets professionals, buy-side analysts and portfolio managers. Learn more
Latest Blog Posts
April 15th, 2015
Compiling a list of needs and wants is valuable to companies searching for an investment bank, especially given how frequently they fail to evaluate a key feature: the banks’ institutional sales forces. Companies frequently make the mistake of considering the right sales force a want-to-have feature, when they should have considered it a must-have.
April 8th, 2015
Last year was a record for biotechnology IPOs, with some 82 companies raising a combined $5.5 billion. Not all IPOs are created equal, however. A good IPO is one that benefits all stakeholders and leaves the door open to future mutually beneficial collaboration. What, then, are the secrets of successful IPOs? For investors to make money on an IPO, the share price needs to rise in the short-, medium-, and long-terms.
March 18th, 2015
A CEO transition can be a time of great risk for a company’s stock as Wall Street attempts to determine all that the change signals. If a change in leadership is not communicated properly it could make your investors nervous. Effectively communicating the CEO succession can help boost confidence in investors — and prevent long term harm to your share price.